Time-Varying Analyses of Survival and Outcomes in Patients with HeartMate 3 Left Ventricular Assist Devices
Long-term survival on HeartMate 3 support was favourable in a large single-centre cohort. Strategies to reduce early postoperative risk of neurological events and late risks of gastrointestinal bleeding, infections and other adverse events are needed.
Authors
- Eugene H. Blackstone (ORCID: https://orcid.org/0000-0001-9839-3567)
- Jean‐Luc A. Maigrot (ORCID: https://orcid.org/0000-0003-2632-3142)
- G. André Ng (ORCID: https://orcid.org/0000-0001-5965-0671)
- Maria Mountis
- Edward G. Soltesz
- Shinya Unai (ORCID: https://orcid.org/0000-0001-6844-073X)
- Pavan Bhat (ORCID: https://orcid.org/0000-0001-8955-1586)
- Aaron Weiss (ORCID: https://orcid.org/0000-0002-3531-4144)
- Nicholas G. Smedira (ORCID: https://orcid.org/0000-0002-4963-8588)
- Lucy Thuita (ORCID: https://orcid.org/0000-0002-3235-5530)
- Michael Z.Y. Tong
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1002/ejhf.3577
- Citations
- 5
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 3.37